Patents
Sitemap › C12 - Biochemistry; Beer; Spirits; Wine; Vinegar; Microbiology; Enzymology; Mutation or genetic engineering › C12N - Micro-organisms or enzymes; Compositions thereof; Propagating, preserving, or maintaining micro-organisms; Mutation or genetic engineering; Culture media › C12N 5 - Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
Patents for C12N 5 - Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor (182,629)
03/2002
03/20/2002EP1187908A1 42 human secreted proteins
03/20/2002EP1187852A1 EXPRESSION AND EXPORT OF INTERFERON-ALPHA PROTEINS AS Fc FUSION PROTEINS
03/20/2002EP1187849A1 Meth1 and meth2 polynucleotides and polypeptides
03/20/2002EP1187843A1 Angiogenic proteins and uses thereof
03/20/2002EP1187842A1 Human tumor necrosis factor receptor tr10
03/20/2002EP1187841A1 Method for enhanced protein stabilization and production of cell lines useful for production of such stabilized proteins
03/20/2002EP1187530A1 Improved storage and maintenance of blood products including red blood cells and platelets
03/20/2002EP1139101A9 Immunoassay for c-reactive protein
03/20/2002EP0920248B1 Biological material embedded in hydrogels, a process for the embedding thereof, and its use as artificial seed
03/20/2002EP0591385B1 Treatment of diseases by site-specific instillation of cells or site-specific transformation of cells and kits therefor
03/20/2002EP0589961B1 Assay systems for neurotrophin activity
03/20/2002EP0418316B1 Platelet-specific chimeric immunoglobulin
03/20/2002CN1341151A Herbicide target gene and methods
03/20/2002CN1341148A Nucleic acid molecules encoding alternansucrase
03/20/2002CN1341147A Method for in vitro fertilisation of meiosis activating sterols (mas)
03/20/2002CN1341121A Expression and export of anti-obesity proteins as Fc fusion proteins
03/20/2002CN1341120A 骨刺激因子 Bone stimulator
03/20/2002CN1340626A Actin gene promotor for Japanese prawn
03/20/2002CN1340611A Medusa-snow lotus cell line for generating flavone with high output
03/20/2002CN1340610A Medusa-snow lotus cell line for generating flavone with high output
03/19/2002USRE37596 Hybridoma cell line which produces the monoclonal antibody bw sclc-1 having the deposit number ecacc no. 90022110.
03/19/2002US6359197 Regulatory sequences for use in delaying leaf aging in plants
03/19/2002US6359126 Antibodies to αvβ3 integrin
03/19/2002US6359116 Compounds
03/19/2002US6359115 Human receptor tyrosine kinase, KDR
03/19/2002US6358923 Preventing and diagnosing blood, genetic, and nervous system disorders associated with decreased genetic expression
03/19/2002US6358920 Nonapeptide anticarcinogenic and antimetastasis agents
03/19/2002US6358916 Biological activity of IGF-I E domain peptide
03/19/2002US6358742 Evolving conjugative transfer of DNA by recursive recombination
03/19/2002US6358741 Polynucleotide coding propagation regulator; for treating cell proliferative defects
03/19/2002US6358739 Transiently immortalized cells
03/19/2002US6358737 Osteocyte cell lines
03/19/2002US6358736 Amplifying preferential polypeptide in tumor cell; obtain cells, incubate with modulator, monitor calcium concentration in cells
03/19/2002US6358723 Deoxyribonuclease IIβ proteins and cDNAs
03/19/2002US6358716 Method for the production of glycerol by recombinant organisms
03/19/2002US6358710 Humanized antibodies that bind to the antigen bound by antibody NR-LU-13
03/19/2002US6358709 End selection in directed evolution
03/19/2002US6358708 Nucleotide sequence coding segment of enzymatic polypeptide; for use in treatment and prevention of fungal infections; fungicides
03/19/2002US6358707 Polynucleotide sequences coding polypeptide associated with cellular secretion; for use in treatment of diabetes, stroke, atherosclerosis, restenosis, thrombosis, autoimmune disease, psoriasis, arthritis, crohn's, and inflammatory defects
03/19/2002US6358706 Nucleotide sequences coding membrane protein; for use in treatment of epilepsy, schizophrenia, depression, sleep, stress, muscle, endocrine, respiratory, fertility, contraceptive, cardiovascular disorders and atherosclerosis
03/19/2002US6358704 M protein
03/19/2002US6358703 Expression system for factor VIII
03/19/2002US6358701 A dna molecule encoding a protein; screening agonists and antagonsits; to determining channel modulators that may have insecticidal, mitacidal and/or nematocidal activity
03/19/2002US6358694 Culturing prostaglandin receptor expressing cells in the presence of a test compound; measure the modulating affects of the compound that interacts with the recombinant receptor and compare the affects with a control host cell
03/19/2002US6358693 AMPA-binding human gluR4 receptor methods
03/19/2002US6358688 Immortalized human middle ear epithelial cell lines
03/19/2002US6358509 Administering to animal a polypeptide wherein animal produces antibodies against polypeptide, antibodies being able to specifically bind to human il-4 and are able to inhibit binding of human il-4 to cellular receptors
03/19/2002US6358506 Removing peripheral blood mononuclear cells (pbmc) from patient; treating said cells with a regulatory composition for a time sufficient to suppress said cells' aberrant immune responses; reintroducing cells to patient
03/19/2002US6357596 Sperm strainer system
03/19/2002CA2250036C Antibiotic cocktail and method of use
03/15/2002CA2357279A1 Composition for density gradient cell separation
03/15/2002CA2357074A1 Novel bcl-2 related proline rich protein (bpr)
03/15/2002CA2339327A1 Vaccines and agents for inducing immunity in fish against rickettsial diseases, and associated preventative therapy
03/14/2002WO2002020848A2 Gene and sequence variation associated with cancer
03/14/2002WO2002020847A2 Gene and sequence variation associated with lipid disorder
03/14/2002WO2002020830A2 Test systems based on transmembrane receptors from helminths and the use thereof for identifying and characterizing compounds
03/14/2002WO2002020825A1 Method and compositions for isolating metastatic cancer cells, and use in measuring metastatic potential of a cancer thereof
03/14/2002WO2002020823A2 Methods and compositions for visualizing and interfering with chromosomal tethering of extrachromosomal molecules
03/14/2002WO2002020814A1 Self-rearranging dna vectors
03/14/2002WO2002020813A2 Recombinant endothelial cell growth inhibitors derived from a mammalian plasminogen
03/14/2002WO2002020812A1 Genetic engineering of syringyl-enriched lignin in plants
03/14/2002WO2002020802A1 A cell line expressing mutant human tissue-type plasminogen activator, constructing strategy and method of expressed protein preparation
03/14/2002WO2002020788A2 Isolated human transporter proteins, nucleic acid molecules encoding human transporter proteins, and uses thereof
03/14/2002WO2002020772A1 Manipulation of plant senescence using an myb gene promoter and cytokinin biosynthesis genes
03/14/2002WO2002020767A2 G-csf analog compositions and methods
03/14/2002WO2002020766A2 G-csf analog compositions and methods
03/14/2002WO2002020764A2 Isolated human transporter proteins, nucleic acid molecules encoding human transporter proteins, and uses thereof
03/14/2002WO2002020763A2 Isolated human transporter proteins, nucleic acid molecules encoding human transporter proteins, and uses thereof
03/14/2002WO2002020762A2 Tnf receptor-like molecules and uses thereof
03/14/2002WO2002020757A2 Isolated human transporter proteins, nucleic acid molecules encoding human transporter proteins, and uses thereof
03/14/2002WO2002020749A2 Chimeric reporter system for cell surface receptor-ligand binding
03/14/2002WO2002020736A2 Proteases
03/14/2002WO2002020733A2 Genes involved in isoprenoid compound production
03/14/2002WO2002020730A2 Manganese lipoxygenase
03/14/2002WO2002020729A2 In vitro human angiogenesis model
03/14/2002WO2002020721A2 Vectors derived from south african arbovirus no. 86
03/14/2002WO2002020718A2 Osteoclast-associated receptor
03/14/2002WO2002020717A2 Methods for simultaneous control of lignin content and composition, and cellulose content in plants
03/14/2002WO2002020714A1 Method and apparatus for peeling cells from vital tissue
03/14/2002WO2002020620A2 Monoclonal antibody against ovarian carcinoma
03/14/2002WO2002020619A2 HUMAN ANTIBODIES AGAINST PSEUDOMONAS AERUGINOSA LPS DERIVED FROM TRANSGENIC XENOMOUSE$m(3)
03/14/2002WO2002020615A2 Antibody and/or chemokine constructs which bind to a chemokine receptor and their use in immunological disorders
03/14/2002WO2002020611A1 Recombinant fusion protein for diagnosis of tsutsugamushi disease
03/14/2002WO2002020569A2 Mammalian genes; related reagents and methods
03/14/2002WO2002020565A2 Collections of repeat proteins comprising repeat modules
03/14/2002WO2002020563A2 RECEPTOR IN THE EDb FIBRONECTIN DOMAIN
03/14/2002WO2002020562A2 Family member of inhibitor of apoptosis proteins
03/14/2002WO2002020560A1 Novel human cancer/testis antigen and gene thereof
03/14/2002WO2002020547A1 Antisense modulation of bh3 interacting domain death agonist expression
03/14/2002WO2002020038A2 Method for down-regulating ige
03/14/2002WO2002019893A2 Improved cardiac function through administration of es cells
03/14/2002WO2002019812A2 Mutant non-human mammal for expressing the alpha6 acetylcholine nicotinic receptor subunit and use for screening substances capable of interacting with said receptor
03/14/2002WO2002019803A1 Disease-resistant plants and method of constructing the same
03/14/2002WO2001090189A3 G-protein coupled receptor org3.
03/14/2002WO2001085981A3 Methods for stimulating nervous system regeneration and repair by regulating arginase i and polyamine synthesis
03/14/2002WO2001081600A3 Transgenic plants
03/14/2002WO2001081581A3 Compositions and methods for the therapy and diagnosis of acne vulgaris
03/14/2002WO2001079502A3 Vectors for gene therapy
03/14/2002WO2001078575A3 Ext2 as a predictive marker for osteoporosis
03/14/2002WO2001077147A3 New bromodomain protein
1 ... 1353 1354 1355 1356 1357 1358 1359 1360 1361 1362 1363 1364 1365 1366 1367 1368 1369 1370 1371 1372 1373 ... 1827